Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
An easy reference to world market indices names, with notes on regional coverage and how to recognize key benchmarks in discussions.
28,183 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
When choosing biotech ETFs, investors face a trade-off between concentration and breadth. This article compares FBT a...
Bitcoin dives again after Friday’s jobs data, erasing a midweek rally as risk-off sentiment spreads. Prices hovered a...
Bitwise CIO Matt Hougan frames crypto as a contrarian bet for institutional buyers, a view that comes as AI stocks su...
Tesla stock can swing on headlines and catalysts. This guide shows you how to decide whether you should wait tesla st...
The memory market has reshaped profits for chip makers and device companies. This article explains how Micron benefit...
Apple may be eyeing a breakthrough to reduce on-device memory needs, a move that could shake Micron and the broader m...
JetBlue sparked attention by boosting its Q2 unit-revenue outlook, lifting airline sentiment and offering clues for t...
Choosing a broad-market ETF can feel like splitting hairs. This guide compares VTI and SCHB on cost, exposure, and re...
A small, overlooked quantum company could ride a wave of lab-to-market commercialization. This guide breaks down why ...
Markets are sizzling, but does that change the wisdom of simply following the S&P 500? This guide breaks down the rea...
Investing beyond U.S. borders can boost diversification and resilience. Learn why IEFA stands out as a top internatio...